Search:
SHARE PRINT

Phase III (2011-15)

In 2010, the GAVI Alliance Board approved a second five-year strategy to support its mission and a business plan in place to guide implementation


GAVI’s second five year strategy (2011-2015), approved by the GAVI Board in June 2010, takes on board lessons from the previous 10 years and sets the roadmap for the next stage of the Alliance’s mission: completing the introduction of pentavalent vaccines and accelerating the delivery of a new generation of life-saving vaccines, in particular rotavirus and pneumococcal, to the world’s poorest countries. It also lays the groundwork for the achievement of GAVI’s objectives beyond 2015.

The 2011-2015 strategy has four goals, each supporting GAVI’s overall mission:

Strategic goal 1: accelerate the uptake and use of underused and new vaccines;

Strategic goal 2: contribute to strengthening the capacity of integrated health systems to deliver immunisation;

Strategic goal 3: increase the predictability of global financing and improve the sustainability of national financing for immunisation;

Strategic goal 4: shape vaccine markets.

The strategy also includes two cross-cutting areas: Monitoring and Evaluation, and Advocacy, Communication and Public Policy.

Business plan

In November 2010, the GAVI Board approved a business plan designed to implement the strategy and ensure that GAVI’s day-to-day activities deliver on its overall mission. The 2011-15 business plan includes:

  • defined targets and goal-level indicators;
  • 26 programme objectives with measurable deliverables;
  • detailed activities and 2011-2012 budgets.

Stepping stones to a strategy
Development of the new strategy kicked-off at the 2009 GAVI Partners’ Forum in Hanoi, Vietnam. From November 2009 through to April 2010, GAVI’s Executive Office conducted a series of one-on-one and group interviews with all Board constituencies.

To ensure maximum transparency:

  • an internal Secretariat task team and external advisory group were appointed;
  • input was received from the Executive Committee of the Board, while consultations were held with the Programme and Policy Committee and the Audit and Finance Committee;
  • feedback was requested from all Ministers of Health of GAVI-eligible countries;
  • a web-based questionnaire was run from February to March 2010;
  • consultations held at WHO/UNICEF regional meetings, with civil society organisations and with EPI managers from the Eastern Mediterranean region.